1. Home
  2. VERA vs ARDT Comparison

VERA vs ARDT Comparison

Compare VERA & ARDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • ARDT
  • Stock Information
  • Founded
  • VERA 2016
  • ARDT 2001
  • Country
  • VERA United States
  • ARDT United States
  • Employees
  • VERA N/A
  • ARDT N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • ARDT
  • Sector
  • VERA Health Care
  • ARDT
  • Exchange
  • VERA Nasdaq
  • ARDT NYSE
  • Market Cap
  • VERA 2.7B
  • ARDT 2.8B
  • IPO Year
  • VERA 2021
  • ARDT 2024
  • Fundamental
  • Price
  • VERA $33.37
  • ARDT $14.10
  • Analyst Decision
  • VERA Buy
  • ARDT Buy
  • Analyst Count
  • VERA 8
  • ARDT 11
  • Target Price
  • VERA $63.50
  • ARDT $22.00
  • AVG Volume (30 Days)
  • VERA 749.7K
  • ARDT 276.6K
  • Earning Date
  • VERA 11-07-2024
  • ARDT 02-22-2025
  • Dividend Yield
  • VERA N/A
  • ARDT N/A
  • EPS Growth
  • VERA N/A
  • ARDT N/A
  • EPS
  • VERA N/A
  • ARDT 0.64
  • Revenue
  • VERA N/A
  • ARDT $5,705,817,000.00
  • Revenue This Year
  • VERA N/A
  • ARDT $10.20
  • Revenue Next Year
  • VERA N/A
  • ARDT $7.83
  • P/E Ratio
  • VERA N/A
  • ARDT $21.88
  • Revenue Growth
  • VERA N/A
  • ARDT 11.23
  • 52 Week Low
  • VERA $14.20
  • ARDT $13.69
  • 52 Week High
  • VERA $51.61
  • ARDT $20.72
  • Technical
  • Relative Strength Index (RSI)
  • VERA 22.57
  • ARDT N/A
  • Support Level
  • VERA $31.77
  • ARDT N/A
  • Resistance Level
  • VERA $36.28
  • ARDT N/A
  • Average True Range (ATR)
  • VERA 2.18
  • ARDT 0.00
  • MACD
  • VERA -0.86
  • ARDT 0.00
  • Stochastic Oscillator
  • VERA 13.34
  • ARDT 0.00

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About ARDT ARDENT HEALTH PARTNERS INC

Ardent Health Partners Inc is an operator of hospitals and a provider of healthcare services in the United States. It provide both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. The company has one reportable segment: healthcare services that provides healthcare services primarily through its ownership and operation of hospitals, certain of which provide related healthcare services through physician practices, outpatient centers, and post-acute facilities. Ardent has 30 acute care hospitals, more than 200 sites of care that operates across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas.

Share on Social Networks: